<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.11215.021</object-id><label>Table 1.</label><caption><p>RPB1 CTD peptides.&#160;CTD peptides with unmodified, mono-, di-, tri-methyl and acetyl K7 residues were used in ELISA assays to characterize the specificity of the CTD methyl antibodies produced in this study.&#160;</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.11215.021">http://dx.doi.org/10.7554/eLife.11215.021</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Peptide sequence</th><th>Modification</th></tr></thead><tbody><tr><td>SYSPTSP<bold>K</bold>YTPTSPSC</td><td>Unmodified</td></tr><tr><td>SYSPTSP<bold>Kme1</bold>YTPTSPSC</td><td>K7 monomethyl</td></tr><tr><td>SYSPTSP<bold>Kme2</bold>YTPTSPSC</td><td>K7 dimethyl</td></tr><tr><td>SYSPTSP<bold>Kme3</bold>YTPTSPSC</td><td>K7 trimethyl</td></tr><tr><td>SYSPTSP<bold>Kac</bold>YTPTSPSC</td><td>K7 acetyl</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>CTD, C-terminal domain; ELISA, enzyme-linked immunosorbent assay.</p></fn></table-wrap-foot></table-wrap>